Company intelligence / Profile preview

PamGene

Den Bosch ('s-Hertogenbosch), Netherlandspamgene.com ↗

Ownership: Private
Development stage: Commercial

Overview

PamGene offers multiplex functional kinase activity profiling using its proprietary microarray-based platform. This enables real-time measurement of cellular signaling dynamics to support biomarker discovery, target identification/validation, mechanism-of-action studies for drugs in preclinical through clinical research settings. The company provides both contract research services and instrument sales with training/support for integration into client labs.

Therapeutic areas: OncologyMetabolic DisordersImmunologyCardiovascularNeurologyInfectious Diseases
Modalities: Small moleculeMonoclonal antibody
Industry: Drug Discovery Services

Drug pipeline

2 assets

IOpener-melanoma

Commercial

Indications: Melanoma

1 more asset in the full pipeline.

Request access →

Beyond the preview

Go deeper on PamGene.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PamGene.

Explore the full profile